+ New Watchlist

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

SPDR Series Trust SPDR S&P Biotech ETF

XBIARCA

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$91.28

1.471.64%

At close: -

$91.68

0.400.44%

After Hours: Dec 20, 7:56 PM EDT

News

Holdings Dividends Short Interest

Latest news for SPDR Series Trust SPDR S&P Biotech ETF (ARCA:XBI)

SPDR Series Trust SPDR S&P Biotech ETF (ARCA: XBI)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, December 18, 2024

20 ETFs Primed For Unusually Big Swings On Fed Meeting Days
Piero Cingari

Monday, December 16, 2024

Live On CNBC, Joe Terranova Announces Sold SP...
Benzinga Newsdesk

Monday, November 18, 2024

A Must See Chart For Prudent Investors, Trump To Help Tesla Dominate, Nvidia Heat Problem
The Arora Report

Monday, August 19, 2024

On CNBC, Joe Terranova Announces Sold SPDR Se...
Benzinga Newsdesk

Wednesday, July 31, 2024

Should You Invest in the iShares Biotechnology ETF?
Zacks

Monday, July 29, 2024

CNBC Halftime Report Final Trades: Amazon.com...
Benzinga Newsdesk

Monday, July 01, 2024

Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows
Piero Cingari

Monday, June 24, 2024

5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
Shanthi Rexaline

Wednesday, June 12, 2024

Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React
Piero Cingari

Tuesday, June 04, 2024

American Express, Trade Desk And More: CNBC's 'Final Trades'
Avi Kapoor

Monday, June 03, 2024

CNBC Halftime Report Final Trades: American E...
Benzinga Newsdesk

Thursday, May 09, 2024

Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
Shanthi Rexaline

Thursday, April 04, 2024

Clean Energy, Semiconductors Among Interest-Rate-Sensitive Sectors Hammered Thursday Afternoon On Rate Cut Concerns
Aaron Bry

Wednesday, February 28, 2024

Biotech Stocks Surge To Start 2024: 'Charts Look Great,' But Will The Trend Continue?
Erica Kollmann
Opportunities For Investors Beyond AI And Nvidia – Biotech Breaks Out, New GDP Data Shows Inflation Pressure
The Arora Report

Monday, January 08, 2024

5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway Monday
Shanthi Rexaline

Wednesday, January 03, 2024

Satori Fund's Dan Niles Names Amazon, Meta Top Stocks To Own In 2024
Adam Eckert

Thursday, December 21, 2023

Top 7 Trending Stocks On WallStreetBets As Of...
Benzinga Newsdesk

Thursday, December 14, 2023

US Stocks Eye 7-Day Winning Streak As Mortgage Rates Fall Below 7%, Yields Tumble: What's Driving Markets Thursday?
Piero Cingari

Wednesday, December 13, 2023

Stocks Hold Steady, Yields Decline As Fed Meeting Looms: What's Driving Markets Wednesday?
Piero Cingari

Monday, December 04, 2023

Fed Rate Cut Speculations Rattle Stocks, Commodities Slide, Bitcoin Shines: What's Driving Markets Monday?
Piero Cingari

Friday, December 01, 2023

Stocks, Gold, Bonds Rally Further, Dollars Tumbles As Traders Anticipate Fed Cuts: What's Driving Markets Friday?
Piero Cingari

Thursday, November 30, 2023

S&P 500, Nasdaq Slip As Tech Underperforms, Oil Reacts to OPEC+: What's Driving Markets Thursday?
Piero Cingari

Wednesday, November 29, 2023

Stocks Drift Higher On Stronger GDP Data, Oil Rebounds As OPEC+ Mulls Cuts: What's Driving Markets Wednesday?
Piero Cingari

Tuesday, November 28, 2023

US Stocks Rebound As Treasury Yields, Dollar Fall On Dovish Fed Remarks, Gold Hits $2,040: What's Driving Markets Tuesday?
Piero Cingari

Friday, September 08, 2023

EXCLUSIVE: Kidney Care Revolution? How Swedish Biopharma Calliditas Aims To Tackle A Rare Disease With 'Unique, But Pretty Simple' Drug
Shanthi Rexaline

Friday, August 25, 2023

If You Invested $1000 In Vivek Ramaswamy-Founded Roivant When He Declared Presidential Bid, Here's How Much You'd Have Now
Shanthi Rexaline

Wednesday, June 28, 2023

ETF Returns: Mid-Cap Winners And Losers
Johnny Rice

Sunday, April 30, 2023

Here Are The Best-Performing Industry ETFs And Major Stock Contributors In April
Piero Cingari

Thursday, April 20, 2023

Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names
Ryan Glosier

Friday, April 14, 2023

Thermo Fisher, Principal Financial Group, And Two Promising ETFs Steal The Show On CNBC's 'Final Trades'
Lisa Levin

Thursday, April 13, 2023

Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
Vandana Singh
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
Vandana Singh

Wednesday, April 12, 2023

New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
Vandana Singh

Tuesday, April 11, 2023

Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
Vandana Singh

Thursday, April 06, 2023

FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits
Vandana Singh

Friday, March 31, 2023

Top 5 Best And Worst U.S. Industry ETFs In Q1 2023: AI and Bank Turmoil Shaped Stock Returns
Piero Cingari

Thursday, March 16, 2023

US Judge Weighs Nationwide Ban On Abortion Pills
Vandana Singh

Monday, March 13, 2023

Silicon Valley Bank Meltdown Hits Healthcare Sector As Well
Vandana Singh

Friday, March 10, 2023

Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs
Vandana Singh
FDA Seeks 10% Increase In Biden's FY 2024 Budget, Proposes Enhancing Regulatory Authorities
Vandana Singh

Wednesday, March 01, 2023

FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
Vandana Singh

Tuesday, January 31, 2023

Stryker, DaVita And These 2 ETFs: CNBC's 'Final Trades'
Lisa Levin

Tuesday, December 27, 2022

Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
Shanthi Rexaline

Friday, December 02, 2022

Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
Shanthi Rexaline

Thursday, December 01, 2022

BriaCell's Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
Faith Ashmore - Sponsored

Tuesday, November 22, 2022

The 10 Most Shorted ETFs: Which Sectors Saw Short Interest Increase?
Chris Katje

Monday, November 21, 2022

Devon Energy, Service Now, WR Berkley And This Biotech Play On CNBC's 'Final Trades'
Priya Nigam

Tuesday, November 01, 2022

What To Watch In The S&P Biotech ETF After Johnson & Johnson's $16.6B Abiomed Deal
Joel Elconin

Monday, October 03, 2022

ExxonMobil And Biotech: How To Play A Declining Market
Priya Nigam

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved